Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for NXTCL with the United States Patent and Trademark Office. The USPTO has given the NXTCL trademark a serial number of 79442092. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 22, 2026. This trademark is owned by NextCell Pharma AB. The NXTCL trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Science and technology services; research services; scientific research and development; medical and pharmacological research services; laboratory services; analytical laboratory services; scientific services relating to the isolation and cultivation of human tissues and cells; consultancy in the field of scientific research; advisory services relating to scientific research; providing information about industrial analysis and research services; research laboratories; provision of information relating to scientific research; research and development of new products for others; scientific research for medical purposes; laboratory research services relating to pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; clinical trials; culturing of cells for scientific research purposes; stem cell research; quality control and authentication services; providing scientific research information...
Chemicals used in science; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for scientific use; biological preparations [other than for medical use]; cultures of cell media [other than for medical or veterinary use].
Live organs and tissues for surgical purposes; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; stem cells; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune diseases; cell growth media for growing cells for medical use.